Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Optimization of Plerixafor Utilization Based on Peripheral Blood CD34+ Count for Autologous Peripheral Blood Stem-Cell Collection

Gaurav K. Gupta, MDPhD, Sera Perreault, PharmD, Stuart Seropian, MD, Christopher A. Tormey, MD, Jeanne E. Hendrickson, MD

Blood (2020) 136 (Supplement 1): 41.

https://doi.org/10.1182/blood-2020-140171

Published: 2020

Journal Articles

Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience

Sabrina L. Browning, MD, Michael Gormally, MD PhD, Neima Briggs, MD PhD, Muyi Li, MD, Alan Zakko, MD, Maudry Laurent-Rolle, MD PhD, Joseph Ladines-Lim, MD, Alyssa Morrison, BS, MS2, Prakash Kandel, MD, Mohammad Khan, MD, Gavin X. McLeod, MD, Gregory K. Buller, MD FACP, Kent A. Owusu, PharmD, Miriam M. Treggiari, MD PhD MPH, Jeanne E. Hendrickson, MD, Christopher A. Tormey, MD, Mahalia S. Desruisseaux, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-137352

Published: 2020

Journal Articles

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

George Goshua, MD, Pranay Sinha, MD, Jeanne E. Hendrickson, MD, Christopher A. Tormey, MD, Pavan Bendapudi, MD, Alfred Ian Lee, MD PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-138515

Published: 2020

Journal Articles

The Presence and Persistence of Pregnancy-Associated Red Blood Cell Alloantibodies in Blood Donors

Raisa Balbuena-Merle, MD, Ronald G. Hauser, MD, Matthew Karafin, MD, Sylvia Tan, MS, Bryan R Spencer, MPH, PhD, Nareg Roubinian, MD, Yanyun Wu, MD PhD, Darrell Triulzi, MD, Steven Kleinman, MD, Jerry Gottschall, MD, Christopher A. Tormey, MD, Jeanne E. Hendrickson, MD

Blood (2019) 134 (Supplement_1): 2452.

https://doi.org/10.1182/blood-2019-121388

Published: 2019

Journal Articles

Duffy Antigen Phenotyping Is a Useful and Clinically Available Test for Benign Ethnic Neutropenia

Eric Y. Chang, MD, Christopher A. Tormey, MD, Alexa J. Siddon, MD, Mahboubeh Rahmani, MD, Ellice Y. Wong, MD

Blood (2018) 132 (Supplement 1): 2546.

https://doi.org/10.1182/blood-2018-99-117178

Published: 2018

Journal Articles

Epidemiologic Characterization of Transfusion Recipients with Red Blood Cell Alloantibodies from Four US Regions: Evidence from the REDS-III Recipient Database

Matthew S. Karafin, MD, Matt Westlake, Ronald G. Hauser, MD, Christopher A. Tormey, MD, Philip L Norris, MD, Nareg H. Roubinian, MD, Yanyun Wu, MD PhD, Steven Kleinman, MD, Jeanne E. Hendrickson, MD

Blood (2017) 130 (Supplement 1): 1132.

https://doi.org/10.1182/blood.V130.Suppl_1.1132.1132

Published: 2017

Journal Articles

The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban

Debbie Jiang, MD, Anne Dumont, RN, Adrienne J. Burns, MMS, PA-C, Henry Rinder, MD, Christopher A. Tormey, MD, Alfred Lee, MD PhD

Blood (2017) 130 (Supplement 1): 3741.

https://doi.org/10.1182/blood.V130.Suppl_1.3741.3741

Published: 2017

Journal Articles

Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies

Mariette Asare, MD, Jeanne E Hendrickson, MD, Christopher A Tormey, MD

Blood (2016) 128 (22): 1463.

https://doi.org/10.1182/blood.V128.22.1463.1463

Published: 2016

Journal Articles

Daratumumab Interferes with Flow Cytometric Evaluation of Multiple Myeloma

Sudhir Perincheri, PhD MBBS, Richard Torres, MD, Christopher A Tormey, MD, Brian R Smith, MD, Henry M Rinder, MD, Alexa J Siddon, MD

Blood (2016) 128 (22): 5630.

https://doi.org/10.1182/blood.V128.22.5630.5630

Published: 2016

Journal Articles

Impact of Molecular Clonality on Survival in Acute Myeloid Leukemia

Wade L Schulz, MD PhD, Thomas JS Durant, MD, Henry Rinder, MD, Christopher A Tormey, MD, Richard Torres, MD, Brian R Smith, MD, Karl M Hager, PhD, John G Howe, PhD, Alexa J Siddon, MD

Blood (2015) 126 (23): 1385.

https://doi.org/10.1182/blood.V126.23.1385.1385

Published: 2015

Journal Articles

A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC Alloimmunization

Romulo Celli, MD, Wade L Schulz, MD PhD, Jeanne E. Hendrickson, MD, Christopher A Tormey, MD

Blood (2015) 126 (23): 2349.

https://doi.org/10.1182/blood.V126.23.2349.2349

Published: 2015

Journal Articles

Chronic Inflammatory Autoimmune Disorders Are a Risk Factor for Blood Group Alloimmunization in Transfused Patients

Alex B Ryder, MD, Jeanne E Hendrickson, MD, Christopher A. Tormey, MD

Blood (2014) 124 (21): 4294.

https://doi.org/10.1182/blood.V124.21.4294.4294

Published: 2014

Journal Articles

Polyclonal Anti-Kel (KELGAM) Prevents Alloimmunization to Transfused Kel RBCs in a Murine Model

Sean R. Stowell, MD PhD, Connie M Arthur, PhD, Kathryn R. Girard-Pierce, PhD, Harold Clifford Sullivan, MD, Manjula Santhanakrishnan, Prabitha Natarajan, PhD, Christopher A. Tormey, MD, James C. Zimring, MD PhD, Jeanne E Hendrickson, MD

Blood (2014) 124 (21): 758.

https://doi.org/10.1182/blood.V124.21.758.758

Published: 2014

Journal Articles

Development of a Murine Model of Weak Kel: Similarities to Weak Rh(D)

Jeanne E. Hendrickson, MD, Nicole H. Smith, Kathryn R. Girard-Pierce, Christopher A Tormey, MD, Kate L. Henry, MS, James C. Zimring, MD, PhD, Sean R. Stowell, MD, PhD

Blood (2012) 120 (21): 842.

https://doi.org/10.1182/blood.V120.21.842.842

Published: 2012

NARROW

Optimization of Plerixafor Utilization Based on Peripheral Blood CD34+ Count for Autologous Peripheral Blood Stem-Cell Collection

Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

The Presence and Persistence of Pregnancy-Associated Red Blood Cell Alloantibodies in Blood Donors

Duffy Antigen Phenotyping Is a Useful and Clinically Available Test for Benign Ethnic Neutropenia

Epidemiologic Characterization of Transfusion Recipients with Red Blood Cell Alloantibodies from Four US Regions: Evidence from the REDS-III Recipient Database

The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban

Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies

Daratumumab Interferes with Flow Cytometric Evaluation of Multiple Myeloma

Impact of Molecular Clonality on Survival in Acute Myeloid Leukemia

A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC Alloimmunization

Chronic Inflammatory Autoimmune Disorders Are a Risk Factor for Blood Group Alloimmunization in Transfused Patients

Polyclonal Anti-Kel (KELGAM) Prevents Alloimmunization to Transfused Kel RBCs in a Murine Model

Development of a Murine Model of Weak Kel: Similarities to Weak Rh(D)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only